Hattori et al. evaluated 1321 RA patients and reported that the serum MMP-3 levels were more accurate than the serum CRP levels for assessing the likelihood of achieving SDAI remission and normal physical function [16]. This evidence concerns the gene MMP3 and rheumatoid arthritis.